LifeMD Ships Lilly Self-Pay GLP-1 Medicines

LifeMD's affiliated pharmacy will dispense Zepbound and Foundayo nationwide at Eli Lilly's self-pay price for eligible patients.

Updated on Nov. 5, 2026 in Diabetes

Plain white shipping cartons stacked on a brushed steel counter in a clean, modern pharmacy fulfillment space with empty shelving behind.
LifeMD will dispense Eli Lilly's self-pay Zepbound and Foundayo to eligible patients nationwide, billed outside insurance, starting November 5. AI Illustration. Upload story photo >

Live Poll

Would you consider buying weight-loss medication directly through a cash-pay program?

LifeMD announced on November 5, 2026, an arrangement with Eli Lilly and Company enabling its affiliated pharmacy to dispense and ship Lilly's self-pay GLP-1 medicines across the United States. Eligible patients can purchase Zepbound (tirzepatide) or Foundayo (orforglipron) at Lilly's established self-pay price through LifeMD.

Why it matters

The arrangement gives patients a cash-pay route to branded GLP-1 therapies that is not billed to insurance. LifeMD says it strengthens its vertically integrated care platform for obesity care.

The announcement covers two named medicines, Zepbound (tirzepatide) and Foundayo (orforglipron), sold at a cash-pay price set by Lilly. The source does not disclose the price itself or any patient volume, so the scale of the program cannot yet be measured.

The players

Eli Lilly and Company

Eli Lilly and Company is a major pharmaceutical manufacturer and the developer of the GLP-1 medicines Zepbound and Foundayo.

LifeMD

LifeMD is a Nasdaq-listed provider of virtual primary care that operates a telehealth platform and a licensed mail-order pharmacy.

The details

Eligible patients receive a Lilly medication prescribed by a LifeMD-affiliated healthcare provider after an independent clinical evaluation, and access the program through LifeMD's virtual care platform. Prescriptions are fulfilled and shipped by LifeMD's licensed mail-order pharmacy.

Timeline

  1. November 5, 2026: LifeMD announces the Lilly self-pay dispensing arrangement.

Market Landscape

The deal extends a growing channel in which drugmakers sell branded GLP-1 medicines for cash outside insurance, routed through telehealth providers. It places Lilly's self-pay pricing inside a virtual primary care network rather than a traditional retail pharmacy setting.

Patients who are prescribed Zepbound or Foundayo through LifeMD can buy the medicine at Lilly's self-pay price rather than through insurance. The medication is shipped to them by LifeMD's mail-order pharmacy after a prescription is written.

The takeaway

Patients interested in cash-pay GLP-1 therapy should confirm eligibility and pricing directly with a prescribing provider before enrolling. Insurance coverage will not apply to purchases made through this program.

Further reading

Explore more on Diabetes coverage and treatment options.

Live Poll

Would you consider buying weight-loss medication directly through a cash-pay program?